Low brain intracellular free magnesium in mitochondrial cytopathies

被引:41
作者
Barbiroli, B
Iotti, S
Cortelli, P
Martinelli, P
Lodi, R
Carelli, V
Montagna, P
机构
[1] Dipartimento Med Clin & Biotecnol Applicata D Cam, Biochim Clin, I-40138 Bologna, Italy
[2] Univ Bologna, Ist Clin Neurol, I-40126 Bologna, Italy
关键词
intracellular magnesium; brain; mitochondrial cytopathies; Delta G of ATP hydrolysis; co-enzyme Q(10);
D O I
10.1097/00004647-199905000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The authors studied, by in vivo phosphorus magnetic resonance spectroscopy (P-31-MRS), the occipital lobes of 19 patients with mitochondrial cytopathies to clarify the functional relation between energy metabolism and concentration of cytosolic free magnesium. All patients displayed defective mitochondrial respiration with low phosphocreatine concentration [PCr] and high inorganic phosphate concentration [Pi] and [ADP]. Cytosolic free [Mg2+] and the readily available free energy (defined as the actual free energy released by the exoergonic reaction of ATP hydrolysis, i.e., Delta G(ATPhyd)) were abnormally low in all patients. Nine patients were treated with coenzyme Q(10) (CoQ), which improved the efficiency of the respiratory chain, as shown by an increased [PCr], decreased [Pi] and [ADP], and increased availability of free energy (more negative value of Delta G(ATPhyd)). Treatment with CoQ also increased cytosolic free [Mg2+] in all treated patients. The authors findings demonstrate low brain free [Mg2+] in our patients and indicate that it resulted from failure of the respiratory chain. Free Mg2+ contributes to the absolute value of Delta G(ATPhyd). The results also are consistent with the view that cytosolic [Mg2+] is regulated in the intact brain cell to equilibrate, at least in part, any changes in rapidly available free energy.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 30 条
[1]  
BARBER D, 1993, EDUC TRAIN MENT RET, V28, P13
[2]   DEFECTIVE BRAIN AND MUSCLE ENERGY-METABOLISM SHOWN BY IN-VIVO P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN NONAFFECTED CARRIERS OF 11778-MTDNA MUTATION [J].
BARBIROLI, B ;
MONTAGNA, P ;
CORTELLI, P ;
IOTTI, S ;
LODI, R ;
BARBONI, P ;
MONARI, L ;
LUGARESI, E ;
FRASSINETI, C ;
ZANIOL, P .
NEUROLOGY, 1995, 45 (07) :1364-1369
[3]   ABNORMAL BRAIN AND MUSCLE ENERGY-METABOLISM SHOWN BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN PATIENTS AFFECTED BY MIGRAINE WITH AURA [J].
BARBIROLI, B ;
MONTAGNA, P ;
CORTELLI, P ;
FUNICELLO, R ;
IOTTI, S ;
MONARI, L ;
PIERANGELI, G ;
ZANIOL, P ;
LUGARESI, E .
NEUROLOGY, 1992, 42 (06) :1209-1214
[4]  
BARBIROLI B, 1997, CELL MOL BIOL, V43, P714
[5]   P-31 NMR-SPECTROSCOPY AND ERGOMETER EXERCISE TEST AS EVIDENCE FOR MUSCLE OXIDATIVE PERFORMANCE IMPROVEMENT WITH COENZYME-Q IN MITOCHONDRIAL MYOPATHIES [J].
BENDAHAN, D ;
DESNUELLE, C ;
VANUXEM, D ;
CONFORTGOUNY, S ;
FIGARELLABRANGER, D ;
PELLISSIER, JF ;
KOZAKRIBBENS, G ;
POUGET, J ;
SERRATRICE, G ;
COZZONE, PJ .
NEUROLOGY, 1992, 42 (06) :1203-1208
[6]  
BOTTOMLEY PA, 1989, CLIN CHEM, V35, P392
[7]   MULTIPLE CONTROLS OF OXIDATIVE-METABOLISM IN LIVING TISSUES AS STUDIED BY PHOSPHORUS MAGNETIC-RESONANCE [J].
CHANCE, B ;
LEIGH, JS ;
KENT, J ;
MCCULLY, K ;
NIOKA, S ;
CLARK, BJ ;
MARIS, JM ;
GRAHAM, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) :9458-9462
[8]   Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: A clinical and P-31-MRS study [J].
Cortelli, P ;
Montagna, P ;
Pierangeli, G ;
Lodi, R ;
Barboni, P ;
Liguori, R ;
Carelli, V ;
Iotti, S ;
Zaniol, P ;
Lugaresi, E ;
Barbiroli, B .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 148 (01) :25-31
[9]  
*EEC CONC RES PROJ, 1995, MAGN RESON IMAGING, V13, P115
[10]   PHOSPHORUS MAGNETIC-RESONANCE SPECTROSCOPY OF PATIENTS WITH MITOCHONDRIAL CYTOPATHIES DEMONSTRATES DECREASED LEVELS OF BRAIN PHOSPHOCREATINE [J].
ELEFF, SM ;
BARKER, PB ;
BLACKBAND, SJ ;
CHATHAM, JC ;
LUTZ, NW ;
JOHNS, DR ;
BRYAN, RN ;
HURKO, O .
ANNALS OF NEUROLOGY, 1990, 27 (06) :626-630